IDH1 and anaplastic oligodendroglioma: The IDH1 mutation has been shown to be a stand-alone favorable prognostic element in low-grade oligodendrogliomas (LOs), anaplastic oligodendrogliomas (AOs) particularly when the TP53 is not overexpressed (30).